Rivaroxaban versus warfarin for the management of left ventricle thrombus

BACKGROUND: Rivaroxaban has been recently introduced for the management of non-valvular intra-cardiac thrombosis with variable results. We aimed to compare the results of the off-label use of rivaroxaban versus warfarin in the management of patients with left ventricle (LV) thrombus. This research i...

Descripción completa

Detalles Bibliográficos
Autores principales: Albabtain, Monirah A., Alhebaishi, Yahya, Al-Yafi, Ola, Kheirallah, Hatim, Othman, Adel, Alghosoon, Haneen, Arafat, Amr A., Alfagih, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088413/
https://www.ncbi.nlm.nih.gov/pubmed/33932172
http://dx.doi.org/10.1186/s43044-021-00164-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088413/
https://www.ncbi.nlm.nih.gov/pubmed/33932172
http://dx.doi.org/10.1186/s43044-021-00164-7

Ejemplares similares